메뉴 건너뛰기




Volumn 24, Issue 11, 2007, Pages 913-932

Immunosuppressive therapy in older cardiac transplant patients

Author keywords

Antilymphocyte globulin, therapeutic use; Antithymocyte globulin, therapeutic use; Azathioprine, therapeutic use; Basiliximab, therapeutic use; Ciclosporin, therapeutic use; Corticosteroids, therapeutic use; Daclizumab, therapeutic use; Elderly

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN A; DACLIZUMAB; EVEROLIMUS; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

EID: 36049045884     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200724110-00004     Document Type: Review
Times cited : (20)

References (161)
  • 1
    • 0027184593 scopus 로고
    • Heart transplantation as a treatment option for end-stage heart disease in patients older than 65 years of age
    • Jul-Aug;
    • Heroux AL, Costanzo-Nordin MR, O'Sullivan JE, et al. Heart transplantation as a treatment option for end-stage heart disease in patients older than 65 years of age. J Heart Lung Transplant 1993 Jul-Aug; 12 (4): 573-8
    • (1993) J Heart Lung Transplant , vol.12 , Issue.4 , pp. 573-578
    • Heroux, A.L.1    Costanzo-Nordin, M.R.2    O'Sullivan, J.E.3
  • 2
    • 0026785184 scopus 로고
    • Heart transplantation in patients over 54 years of age with triple-drug therapy immunosuppression
    • Sep-Oct;
    • Fabbri A, Sharples LD, Mullins P, et al. Heart transplantation in patients over 54 years of age with triple-drug therapy immunosuppression. J Heart Lung Transplant 1992 Sep-Oct; 11 (5): 929-32
    • (1992) J Heart Lung Transplant , vol.11 , Issue.5 , pp. 929-932
    • Fabbri, A.1    Sharples, L.D.2    Mullins, P.3
  • 3
    • 0023751568 scopus 로고
    • Heart transplantation in elderly patients
    • Jul-Aug;
    • Olivari MT, Antolick A, Kaye MP, et al. Heart transplantation in elderly patients. J Heart Transplant 1988 Jul-Aug; 7 (4): 258-64
    • (1988) J Heart Transplant , vol.7 , Issue.4 , pp. 258-264
    • Olivari, M.T.1    Antolick, A.2    Kaye, M.P.3
  • 4
    • 0042623539 scopus 로고    scopus 로고
    • Long-term survival (>10 years) of patients >60 years with induction therapy after cardiac transplantation
    • Aug;
    • Zuckermann A, Dunkler D, Deviatko E, et al. Long-term survival (>10 years) of patients >60 years with induction therapy after cardiac transplantation. Eur J Cardiothorac Surg 2003 Aug; 24 (2): 283-91
    • (2003) Eur J Cardiothorac Surg , vol.24 , Issue.2 , pp. 283-291
    • Zuckermann, A.1    Dunkler, D.2    Deviatko, E.3
  • 5
    • 0027074886 scopus 로고
    • Clinical results of heart transplantation in recipients over 55 years of age with donors over 40 years of age
    • Nov-Dec;
    • Luciani GB, Livi U, Faggian G, et al. Clinical results of heart transplantation in recipients over 55 years of age with donors over 40 years of age. J Heart Lung Transplant 1992 Nov-Dec; 11 (6): 1177-83
    • (1992) J Heart Lung Transplant , vol.11 , Issue.6 , pp. 1177-1183
    • Luciani, G.B.1    Livi, U.2    Faggian, G.3
  • 6
    • 0030978796 scopus 로고    scopus 로고
    • Heart transplantation in patients over 54 years of age: Mortality, morbidity and quality of life
    • May;
    • Rickenbacher PR, Lewis NP, Valantine HA, et al. Heart transplantation in patients over 54 years of age: mortality, morbidity and quality of life. Eur Heart J 1997 May; 18 (5): 870-8
    • (1997) Eur Heart J , vol.18 , Issue.5 , pp. 870-878
    • Rickenbacher, P.R.1    Lewis, N.P.2    Valantine, H.A.3
  • 7
    • 0032772491 scopus 로고    scopus 로고
    • An analysis of the effect of age on survival after heart transplant
    • Jul;
    • Borkon AM, Muehlebach GF, Jones PG, et al. An analysis of the effect of age on survival after heart transplant. J Heart Lung Transplant 1999 Jul; 18 (7): 668-74
    • (1999) J Heart Lung Transplant , vol.18 , Issue.7 , pp. 668-674
    • Borkon, A.M.1    Muehlebach, G.F.2    Jones, P.G.3
  • 8
    • 0029715994 scopus 로고    scopus 로고
    • Long-term results of heart transplantation deteriorate more rapidly in patients over 60 years of age
    • Robin J, Ninet J, Tronc F, et al. Long-term results of heart transplantation deteriorate more rapidly in patients over 60 years of age. Eur J Cardiothorac Surg 1996; 10 (4): 259-63
    • (1996) Eur J Cardiothorac Surg , vol.10 , Issue.4 , pp. 259-263
    • Robin, J.1    Ninet, J.2    Tronc, F.3
  • 10
    • 0042844680 scopus 로고    scopus 로고
    • Long-term results of heart transplantation in patients older than 60 years
    • Jul;
    • Demers P, Moffatt S, Oyer PE, et al. Long-term results of heart transplantation in patients older than 60 years. J Thorac Cardiovasc Surg 2003 Jul; 126 (1): 224-31
    • (2003) J Thorac Cardiovasc Surg , vol.126 , Issue.1 , pp. 224-231
    • Demers, P.1    Moffatt, S.2    Oyer, P.E.3
  • 11
    • 0041831167 scopus 로고    scopus 로고
    • Differential characteristics of heart transplantation in patients older than 60 years
    • Aug;
    • Peraira JR, Segovia J, Fuentes R, et al. Differential characteristics of heart transplantation in patients older than 60 years. Transplant Proc 2003 Aug; 35 (5): 1959-61
    • (2003) Transplant Proc , vol.35 , Issue.5 , pp. 1959-1961
    • Peraira, J.R.1    Segovia, J.2    Fuentes, R.3
  • 12
    • 0242468952 scopus 로고    scopus 로고
    • Cardiac transplantation in the older recipient: Excellent long-term survival based on pretransplant screening
    • Nov;
    • Baran DA, Galin ID, Courtney MC, et al. Cardiac transplantation in the older recipient: excellent long-term survival based on pretransplant screening. Transplant Proc 2003 Nov; 35 (7): 2465-7
    • (2003) Transplant Proc , vol.35 , Issue.7 , pp. 2465-2467
    • Baran, D.A.1    Galin, I.D.2    Courtney, M.C.3
  • 13
    • 9744266676 scopus 로고    scopus 로고
    • A comparative analysis of outcome after heart transplantation in patients aged 60 years and older: The University of Alberta experience
    • Nov-Dec;
    • Nagendran J, Wildhirt SM, Modry D, et al. A comparative analysis of outcome after heart transplantation in patients aged 60 years and older: the University of Alberta experience. J Card Surg 2004 Nov-Dec; 19 (6): 559-62
    • (2004) J Card Surg , vol.19 , Issue.6 , pp. 559-562
    • Nagendran, J.1    Wildhirt, S.M.2    Modry, D.3
  • 14
    • 10744220560 scopus 로고    scopus 로고
    • Long-term results of cardiac transplantation in patients 65 years of age and older: A comparative analysis
    • Dec;
    • Morgan JA, John R, Weinberg AD, et al. Long-term results of cardiac transplantation in patients 65 years of age and older: a comparative analysis. Ann Thorac Surg 2003 Dec; 76 (6): 1982-7
    • (2003) Ann Thorac Surg , vol.76 , Issue.6 , pp. 1982-1987
    • Morgan, J.A.1    John, R.2    Weinberg, A.D.3
  • 15
    • 27844569484 scopus 로고    scopus 로고
    • The need for a tailored immunosuppression in older heart transplant recipients
    • Nov;
    • Kaczmarek I, Sadoni S, Schmoeckel M, et al. The need for a tailored immunosuppression in older heart transplant recipients. J Heart Lung Transplant 2005 Nov; 24 (11): 1965-8
    • (2005) J Heart Lung Transplant , vol.24 , Issue.11 , pp. 1965-1968
    • Kaczmarek, I.1    Sadoni, S.2    Schmoeckel, M.3
  • 16
    • 0035071628 scopus 로고    scopus 로고
    • Heart transplantation in patients seventy years of age and older: A comparative analysis of outcome
    • Mar;
    • Blanche C, Blanche DA, Kearney B, et al. Heart transplantation in patients seventy years of age and older: a comparative analysis of outcome. J Thorac Cardiovasc Surg 2001 Mar; 121 (3): 532-41
    • (2001) J Thorac Cardiovasc Surg , vol.121 , Issue.3 , pp. 532-541
    • Blanche, C.1    Blanche, D.A.2    Kearney, B.3
  • 17
    • 34547603040 scopus 로고    scopus 로고
    • Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth official adult heart transplant report - 2007
    • Aug;
    • Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: twenty-fourth official adult heart transplant report - 2007. J Heart Lung Transplant 2007 Aug; 26 (8): 769-81
    • (2007) J Heart Lung Transplant , vol.26 , Issue.8 , pp. 769-781
    • Taylor, D.O.1    Edwards, L.B.2    Boucek, M.M.3
  • 19
    • 33646779150 scopus 로고    scopus 로고
    • Long-term results of tacrolimus monotherapy in cardiac transplant recipients
    • Jun;
    • Lubitz SA, Baran DA, Alwarshetty MM, et al. Long-term results of tacrolimus monotherapy in cardiac transplant recipients. J Heart Lung Transplant 2006 Jun; 25 (6): 699-706
    • (2006) J Heart Lung Transplant , vol.25 , Issue.6 , pp. 699-706
    • Lubitz, S.A.1    Baran, D.A.2    Alwarshetty, M.M.3
  • 20
    • 25844439617 scopus 로고    scopus 로고
    • Aging and the environment: A research framework
    • Geller AM, Zenick H. Aging and the environment: a research framework. Environ Health Perspect 2005; 113 (9): 1257-62
    • (2005) Environ Health Perspect , vol.113 , Issue.9 , pp. 1257-1262
    • Geller, A.M.1    Zenick, H.2
  • 23
    • 33745767702 scopus 로고    scopus 로고
    • Long-term cardiovascular risk in transplantation: Insights from the use of everolimus in heart transplantation
    • Jul;
    • Eisen H. Long-term cardiovascular risk in transplantation: insights from the use of everolimus in heart transplantation. Nephrol Dial Transplant 2006 Jul; 21 Suppl. 3: iii9-13
    • (2006) Nephrol Dial Transplant , vol.21 , Issue.SUPPL. 3
    • Eisen, H.1
  • 24
    • 0037393121 scopus 로고    scopus 로고
    • Immunosuppressive drugs and cancer
    • Vial T, Descotes J. Immunosuppressive drugs and cancer. Toxicology 2003; 185: 229-40
    • (2003) Toxicology , vol.185 , pp. 229-240
    • Vial, T.1    Descotes, J.2
  • 25
    • 0035070003 scopus 로고    scopus 로고
    • Exponentially increased risk of infectious death in older transplant recipients
    • Meier-Krische HU, Ojo A, Hanson J. Exponentially increased risk of infectious death in older transplant recipients. Kidney Int 2001; 59: 1539-43
    • (2001) Kidney Int , vol.59 , pp. 1539-1543
    • Meier-Krische, H.U.1    Ojo, A.2    Hanson, J.3
  • 26
    • 0028199120 scopus 로고
    • Cytomegalovirus infection rate among heart transplant patients in relation to anti-thymocyte immunoglobulin induction therapy: Copenhagen Heart Transplant Group
    • Krogsgaard K, Boesgaard S, Aldershvile J, et al. Cytomegalovirus infection rate among heart transplant patients in relation to anti-thymocyte immunoglobulin induction therapy: Copenhagen Heart Transplant Group. Scand J Infect Dis 1994; 26 (3): 239-47
    • (1994) Scand J Infect Dis , vol.26 , Issue.3 , pp. 239-247
    • Krogsgaard, K.1    Boesgaard, S.2    Aldershvile, J.3
  • 27
    • 0027501649 scopus 로고    scopus 로고
    • Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993 Dec 18-25; 342 (8886-8887): 1514-6
    • Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993 Dec 18-25; 342 (8886-8887): 1514-6
  • 28
    • 0026348598 scopus 로고
    • OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients
    • Nov-Dec;
    • Prieto M, Lake KD, Pritzker MR, et al. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients. J Heart Lung Transplant 1991 Nov-Dec; 10 (6): 901-11
    • (1991) J Heart Lung Transplant , vol.10 , Issue.6 , pp. 901-911
    • Prieto, M.1    Lake, K.D.2    Pritzker, M.R.3
  • 29
    • 0025213242 scopus 로고
    • Prophylactic therapy for rejection after cardiac transplantation: A comparison of rabbit antithymocyte globulin and OKT3
    • Apr;
    • Kirklin JK, Bourge RC, White-Williams C, et al. Prophylactic therapy for rejection after cardiac transplantation: a comparison of rabbit antithymocyte globulin and OKT3. J Thorac Cardiovasc Surg 1990 Apr; 99 (4): 716-24
    • (1990) J Thorac Cardiovasc Surg , vol.99 , Issue.4 , pp. 716-724
    • Kirklin, J.K.1    Bourge, R.C.2    White-Williams, C.3
  • 30
    • 0027391180 scopus 로고
    • A prospective randomized study of prophylactic OKT3 versus equine antithymocyte globulin after heart transplantation: Increased morbidity with OKT3
    • Jan;
    • Macdonald PS, Mundy J, Keogh AM, et al. A prospective randomized study of prophylactic OKT3 versus equine antithymocyte globulin after heart transplantation: increased morbidity with OKT3. Transplantation 1993 Jan; 55 (1): 110-6
    • (1993) Transplantation , vol.55 , Issue.1 , pp. 110-116
    • Macdonald, P.S.1    Mundy, J.2    Keogh, A.M.3
  • 31
    • 0034657283 scopus 로고    scopus 로고
    • Zuckermann AO, Grimm M, Czerny M, et al. Improved long-term results with thymoglobulin induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulins. Transplantation 2000 May 15; 69 (9): 1890-8
    • Zuckermann AO, Grimm M, Czerny M, et al. Improved long-term results with thymoglobulin induction therapy after cardiac transplantation: a comparison of two different rabbit-antithymocyte globulins. Transplantation 2000 May 15; 69 (9): 1890-8
  • 32
    • 0032738939 scopus 로고    scopus 로고
    • A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation
    • Dec;
    • Carrier M, White M, Perrault LP, et al. A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation. J Heart Lung Transplant 1999 Dec; 18 (12): 1218-23
    • (1999) J Heart Lung Transplant , vol.18 , Issue.12 , pp. 1218-1223
    • Carrier, M.1    White, M.2    Perrault, L.P.3
  • 33
    • 13444311969 scopus 로고    scopus 로고
    • Use of basiliximab and cyclosporine in heart transplant patients with preoperative renal dysfunction
    • Feb;
    • Delgado DH, Miriuka SG, Cusimano RJ, et al. Use of basiliximab and cyclosporine in heart transplant patients with preoperative renal dysfunction. J Heart Lung Transplant 2005 Feb; 24 (2): 166-9
    • (2005) J Heart Lung Transplant , vol.24 , Issue.2 , pp. 166-169
    • Delgado, D.H.1    Miriuka, S.G.2    Cusimano, R.J.3
  • 34
    • 33748162571 scopus 로고    scopus 로고
    • Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus antithymocyte globulin as induction therapy after heart transplantation
    • Sep;
    • Bonaros N, Dunkler D, Kocher A, et al. Ten-year follow-up of a prospective, randomized trial of BT563/bb10 versus antithymocyte globulin as induction therapy after heart transplantation. J Heart Lung Transplant 2006 Sep; 25 (9): 1154-63
    • (2006) J Heart Lung Transplant , vol.25 , Issue.9 , pp. 1154-1163
    • Bonaros, N.1    Dunkler, D.2    Kocher, A.3
  • 35
    • 4544325560 scopus 로고    scopus 로고
    • Antithymocyte globulin induction allows a prolonged delay in the initiation of cyclosporine in heart transplant patients with postoperative renal dysfunction
    • Sep 15;
    • Cantarovich M, Giannetti N, Barkun J, et al. Antithymocyte globulin induction allows a prolonged delay in the initiation of cyclosporine in heart transplant patients with postoperative renal dysfunction. Transplantation 2004 Sep 15; 78 (5): 779-81
    • (2004) Transplantation , vol.78 , Issue.5 , pp. 779-781
    • Cantarovich, M.1    Giannetti, N.2    Barkun, J.3
  • 36
    • 85036986309 scopus 로고    scopus 로고
    • Zuckermann A, Dunkler D, Haidbauer B, et al. Thymoglobulin induction therapy creates excellent long-term outcome in patients with positive lymphocyte crossmatch after cardiac transplantation [abstract]. American Transplant Congress; 2004 May 15-19; Boston (MA). Am J Transplant 2004 Mar; 4 Suppl. 8: 65S
    • Zuckermann A, Dunkler D, Haidbauer B, et al. Thymoglobulin induction therapy creates excellent long-term outcome in patients with positive lymphocyte crossmatch after cardiac transplantation [abstract]. American Transplant Congress; 2004 May 15-19; Boston (MA). Am J Transplant 2004 Mar; 4 Suppl. 8: 65S
  • 37
    • 0035993796 scopus 로고    scopus 로고
    • Low incidence of graft arteriosclerosis after cardiac transplantation: Risk factor analysis for patients with induction therapy
    • Aug;
    • Zuckermann A, Ploner M, Czerny M, et al. Low incidence of graft arteriosclerosis after cardiac transplantation: risk factor analysis for patients with induction therapy. Transplant Proc 2002 Aug; 34 (5): 1869-71
    • (2002) Transplant Proc , vol.34 , Issue.5 , pp. 1869-1871
    • Zuckermann, A.1    Ploner, M.2    Czerny, M.3
  • 38
    • 34250777773 scopus 로고    scopus 로고
    • Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond
    • Jul;
    • Mohty M. Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 2007 Jul; 21 (7): 1387-94
    • (2007) Leukemia , vol.21 , Issue.7 , pp. 1387-1394
    • Mohty, M.1
  • 39
    • 1342304173 scopus 로고    scopus 로고
    • Lymphomas after solid organ transplantation: A collaborative transplant study report
    • Opelz G, Döhler B. Lymphomas after solid organ transplantation: a collaborative transplant study report. Am J Transplant 2003; 4: 222-30
    • (2003) Am J Transplant , vol.4 , pp. 222-230
    • Opelz, G.1    Döhler, B.2
  • 40
    • 28444449100 scopus 로고    scopus 로고
    • Incidence and prognosis of cancer following heart transplantation using ATG induction therapy
    • El-Hamamsay I, Stevens LM, Carrier M, et al. Incidence and prognosis of cancer following heart transplantation using ATG induction therapy. Transpl Int 2005; 18 (11): 1280-5
    • (2005) Transpl Int , vol.18 , Issue.11 , pp. 1280-1285
    • El-Hamamsay, I.1    Stevens, L.M.2    Carrier, M.3
  • 41
    • 0034594886 scopus 로고    scopus 로고
    • Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody
    • Mar 2;
    • Beniaminovitz A, Itescu S, Lietz K, et al. Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody. N Engl J Med 2000 Mar 2; 342 (9): 613-9
    • (2000) N Engl J Med , vol.342 , Issue.9 , pp. 613-619
    • Beniaminovitz, A.1    Itescu, S.2    Lietz, K.3
  • 42
    • 24344508163 scopus 로고    scopus 로고
    • A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation
    • Sep;
    • Mehra MR, Zucker MJ, Wagoner L, et al. A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation. J Heart Lung Transplant 2005 Sep; 24 (9): 1297-304
    • (2005) J Heart Lung Transplant , vol.24 , Issue.9 , pp. 1297-1304
    • Mehra, M.R.1    Zucker, M.J.2    Wagoner, L.3
  • 43
    • 21244490121 scopus 로고    scopus 로고
    • Daclizumab to prevent rejection after cardiac transplantation
    • Jun 30;
    • Hershberger RE, Starling RC, Eisen HJ, et al. Daclizumab to prevent rejection after cardiac transplantation. N Engl J Med 2005 Jun 30; 352 (26): 2705-13
    • (2005) N Engl J Med , vol.352 , Issue.26 , pp. 2705-2713
    • Hershberger, R.E.1    Starling, R.C.2    Eisen, H.J.3
  • 44
    • 33745159699 scopus 로고    scopus 로고
    • A randomized multicenter comparison of basiliximab and muromonab (OKT3) in heart transplantation: SIMCOR study
    • Jun 15;
    • Segovia J, Rodriguez-Lambert JL, Crespo-Leiro MG, et al. A randomized multicenter comparison of basiliximab and muromonab (OKT3) in heart transplantation: SIMCOR study. Transplantation 2006 Jun 15; 81 (11): 1542-8
    • (2006) Transplantation , vol.81 , Issue.11 , pp. 1542-1548
    • Segovia, J.1    Rodriguez-Lambert, J.L.2    Crespo-Leiro, M.G.3
  • 45
    • 0027462585 scopus 로고
    • Consensus statement regarding OKT3-induced cytokine-release syndrome and human antimouse antibodies
    • Apr;
    • Norman DJ, Chatenoud L, Cohen D, et al. Consensus statement regarding OKT3-induced cytokine-release syndrome and human antimouse antibodies. Transplant Proc 1993 Apr; 25 (2 Suppl. 1): 89-92
    • (1993) Transplant Proc , vol.25 , Issue.2 SUPPL. 1 , pp. 89-92
    • Norman, D.J.1    Chatenoud, L.2    Cohen, D.3
  • 46
    • 0029887271 scopus 로고    scopus 로고
    • A randomized trial comparing safety and efficacy of OKT3 and a monoclonal anti-interleukin-2 receptor antibody (BT563) in the prevention of acute rejection after heart transplantation
    • Jul 15;
    • van Gelder T, Balk AH, Jonkman FA, et al. A randomized trial comparing safety and efficacy of OKT3 and a monoclonal anti-interleukin-2 receptor antibody (BT563) in the prevention of acute rejection after heart transplantation. Transplantation 1996 Jul 15; 62 (1): 51-5
    • (1996) Transplantation , vol.62 , Issue.1 , pp. 51-55
    • van Gelder, T.1    Balk, A.H.2    Jonkman, F.A.3
  • 47
    • 0025661946 scopus 로고
    • Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients
    • Dec 20;
    • Swinnen LJ, Costanzo-Nordin MR, Fisher SG, et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med 1990 Dec 20; 323 (25): 1723-8
    • (1990) N Engl J Med , vol.323 , Issue.25 , pp. 1723-1728
    • Swinnen, L.J.1    Costanzo-Nordin, M.R.2    Fisher, S.G.3
  • 48
    • 0027969105 scopus 로고
    • Cardiac transplantation: The Stanford experience in the cyclosporine era
    • Sarris GE, Moore KA, Schroeder JS, et al. Cardiac transplantation: the Stanford experience in the cyclosporine era. J Thorac Cardiovasc Surg 1994; 108: 240-5
    • (1994) J Thorac Cardiovasc Surg , vol.108 , pp. 240-245
    • Sarris, G.E.1    Moore, K.A.2    Schroeder, J.S.3
  • 49
    • 0032954561 scopus 로고    scopus 로고
    • Thirty years of cardiac transplantation at Stanford University
    • Robbins R, Barlow C, Oyer P, et al. Thirty years of cardiac transplantation at Stanford University. J Thorac Cardiovasc Surg 1999; 117: 939-44
    • (1999) J Thorac Cardiovasc Surg , vol.117 , pp. 939-944
    • Robbins, R.1    Barlow, C.2    Oyer, P.3
  • 50
    • 0031035801 scopus 로고    scopus 로고
    • Renal function in cardiac transplant recipients: Retrospective analysis of 13 consecutive patients in a single center
    • Tinawi M, Miller L, Bastani B. Renal function in cardiac transplant recipients: retrospective analysis of 13 consecutive patients in a single center. Clin Transplant 1997; 11 (1): 1-8
    • (1997) Clin Transplant , vol.11 , Issue.1 , pp. 1-8
    • Tinawi, M.1    Miller, L.2    Bastani, B.3
  • 51
    • 0030845767 scopus 로고    scopus 로고
    • Cyclosporin nephrotoxicity following cardiac transplantation
    • Woolfson RG, Neild GH. Cyclosporin nephrotoxicity following cardiac transplantation. Nephrol Dial Transplant 1997; 12: 2054-6
    • (1997) Nephrol Dial Transplant , vol.12 , pp. 2054-2056
    • Woolfson, R.G.1    Neild, G.H.2
  • 52
    • 0024237509 scopus 로고
    • Chronic injury of human renal microvessels with low-dose cyclosporine therapy
    • Myers BD, Newton L, Boshkos C, et al. Chronic injury of human renal microvessels with low-dose cyclosporine therapy. Transplantation 1988; 46 (5): 694-703
    • (1988) Transplantation , vol.46 , Issue.5 , pp. 694-703
    • Myers, B.D.1    Newton, L.2    Boshkos, C.3
  • 53
    • 0030898964 scopus 로고    scopus 로고
    • Cyclosporine-associated end-stage nephropathy after cardiac transplantation: Incidence and progression
    • Goldstein DJ, Zuech N, Sehgal V, et al. Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression. Transplantation 1997; 63 (5): 664-8
    • (1997) Transplantation , vol.63 , Issue.5 , pp. 664-668
    • Goldstein, D.J.1    Zuech, N.2    Sehgal, V.3
  • 54
    • 0030966728 scopus 로고    scopus 로고
    • Cardiac allograft rejection: Do trough cyclosporine levels correlate with the grade of histologic rejection?
    • El Gamel A, Keevil B, Rahman A, et al. Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection? J Heart Lung Transplant 1997; 16 (3): 268-74
    • (1997) J Heart Lung Transplant , vol.16 , Issue.3 , pp. 268-274
    • El Gamel, A.1    Keevil, B.2    Rahman, A.3
  • 55
    • 0030679675 scopus 로고    scopus 로고
    • Long-term renal function in heart transplant recipients receiving cyclosporine therapy
    • Goral S, Ynares C, Shyr Y, et al. Long-term renal function in heart transplant recipients receiving cyclosporine therapy. J Heart Lung Transplant 1997; 16 (11): 1106-12
    • (1997) J Heart Lung Transplant , vol.16 , Issue.11 , pp. 1106-1112
    • Goral, S.1    Ynares, C.2    Shyr, Y.3
  • 56
    • 0036753579 scopus 로고    scopus 로고
    • Reversal of chronic cyclosporine nephrotoxicity after heart transplantation-potential role of mycophenolate mofetil
    • Tedoriya T, Keogh AM, Kusano K, et al. Reversal of chronic cyclosporine nephrotoxicity after heart transplantation-potential role of mycophenolate mofetil. J Heart Lung Transplant 2002; 21 (9): 976-82
    • (2002) J Heart Lung Transplant , vol.21 , Issue.9 , pp. 976-982
    • Tedoriya, T.1    Keogh, A.M.2    Kusano, K.3
  • 57
    • 0011236968 scopus 로고    scopus 로고
    • Benefit of mycophenolate- mofetil (MMF) in patients with cyclosporine (CyA) induced nephropathy after cardiac transplantation [abstract]
    • Zuckermann A, Ploner M, Keziban U, et al. Benefit of mycophenolate- mofetil (MMF) in patients with cyclosporine (CyA) induced nephropathy after cardiac transplantation [abstract]. J Heart Lung Transplant 2001; 20 (2): 163
    • (2001) J Heart Lung Transplant , vol.20 , Issue.2 , pp. 163
    • Zuckermann, A.1    Ploner, M.2    Keziban, U.3
  • 58
    • 0036253476 scopus 로고    scopus 로고
    • Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment
    • Snell GI, Levvey BJ, Chin W, et al. Sirolimus allows renal recovery in lung and heart transplant recipients with chronic renal impairment. J Heart Lung Transplant 2002; 21 (5): 540-6
    • (2002) J Heart Lung Transplant , vol.21 , Issue.5 , pp. 540-546
    • Snell, G.I.1    Levvey, B.J.2    Chin, W.3
  • 59
    • 1542719221 scopus 로고    scopus 로고
    • Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients
    • Mar;
    • Grötzner J, Kaczmarek I, Landwehr P, et al. Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients. Eur J Cardiothorac Surg 2004 Mar; 25 (3): 333-41
    • (2004) Eur J Cardiothorac Surg , vol.25 , Issue.3 , pp. 333-341
    • Grötzner, J.1    Kaczmarek, I.2    Landwehr, P.3
  • 60
    • 85036973389 scopus 로고    scopus 로고
    • Sirolimus as rescue therapy in heart transplant recipients with calcineurin induced renal dysfunction [abstract]. American Transplant Congress; 2003 May 30-Jun 4; Washington, DC
    • Zuckermann A, Bodhjalian A, Roedler S, et al. Sirolimus as rescue therapy in heart transplant recipients with calcineurin induced renal dysfunction [abstract]. American Transplant Congress; 2003 May 30-Jun 4; Washington, DC. Am J Transplant 2003; 3 Suppl. 5: 61S
    • (2003) Am J Transplant , vol.3 , Issue.SUPPL. 5
    • Zuckermann, A.1    Bodhjalian, A.2    Roedler, S.3
  • 61
    • 0030753168 scopus 로고    scopus 로고
    • Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine
    • Ventura HO, Malik FS, Mehra MR, et al. Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine. Curr Opin Cardiol 1997; 12 (4): 375-81
    • (1997) Curr Opin Cardiol , vol.12 , Issue.4 , pp. 375-381
    • Ventura, H.O.1    Malik, F.S.2    Mehra, M.R.3
  • 62
    • 0029119711 scopus 로고
    • Effect of pravastatin on outcomes after cardiac transplantation
    • Kobashigawa JA, Katznelson S, Laks H, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995; 333 (10): 621-7
    • (1995) N Engl J Med , vol.333 , Issue.10 , pp. 621-627
    • Kobashigawa, J.A.1    Katznelson, S.2    Laks, H.3
  • 63
    • 27844521938 scopus 로고    scopus 로고
    • Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients
    • Nov;
    • Kobashigawa JA, Moriguchi JD, Laks H, et al. Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients. J Heart Lung Transplant 2005 Nov; 24 (11): 1736-40
    • (2005) J Heart Lung Transplant , vol.24 , Issue.11 , pp. 1736-1740
    • Kobashigawa, J.A.1    Moriguchi, J.D.2    Laks, H.3
  • 65
    • 33646763869 scopus 로고    scopus 로고
    • Advantages of C2 monitoring to avoid acute rejection in pediatric heart transplant recipients
    • Jun;
    • Schubert S, Abdul-Khaliq H, Lehmkuhl HB, et al. Advantages of C2 monitoring to avoid acute rejection in pediatric heart transplant recipients. J Heart Lung Transplant 2006 Jun; 25 (6): 619-25
    • (2006) J Heart Lung Transplant , vol.25 , Issue.6 , pp. 619-625
    • Schubert, S.1    Abdul-Khaliq, H.2    Lehmkuhl, H.B.3
  • 66
    • 33646123088 scopus 로고    scopus 로고
    • Cyclosporine profiling with C2 and C0 monitoring improves outcomes after heart transplantation
    • May;
    • Barnard JB, Thekkudan J, Richardson S, et al. Cyclosporine profiling with C2 and C0 monitoring improves outcomes after heart transplantation. J Heart Lung Transplant 2006 May; 25 (5): 564-8
    • (2006) J Heart Lung Transplant , vol.25 , Issue.5 , pp. 564-568
    • Barnard, J.B.1    Thekkudan, J.2    Richardson, S.3
  • 67
    • 29144516668 scopus 로고    scopus 로고
    • A randomized, controlled trial of C0- vs C2-guided therapeutic drug monitoring of cyclosporine in stable heart transplant patients
    • Dec;
    • Mathias HC, Ozalp F, Will MB, et al. A randomized, controlled trial of C0- vs C2-guided therapeutic drug monitoring of cyclosporine in stable heart transplant patients. J Heart Lung Transplant 2005 Dec; 24 (12): 2137-43
    • (2005) J Heart Lung Transplant , vol.24 , Issue.12 , pp. 2137-2143
    • Mathias, H.C.1    Ozalp, F.2    Will, M.B.3
  • 68
    • 0031682091 scopus 로고    scopus 로고
    • European Multicenter Tacrolimus (FK506) Heart Pilot Study: One-year results. European Tacrolimus Multicenter Heart Study Group
    • Aug;
    • Reichart B, Meiser B, Vigano M, et al. European Multicenter Tacrolimus (FK506) Heart Pilot Study: one-year results. European Tacrolimus Multicenter Heart Study Group. J Heart Lung Transplant 1998 Aug; 17 (8): 775-81
    • (1998) J Heart Lung Transplant , vol.17 , Issue.8 , pp. 775-781
    • Reichart, B.1    Meiser, B.2    Vigano, M.3
  • 69
    • 0032913084 scopus 로고    scopus 로고
    • A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: Decreased hyperlipidemia and hypertension with tacrolimus
    • Apr;
    • Taylor DO, Barr ML, Radovancevic B, et al. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant 1999 Apr; 18 (4): 336-45
    • (1999) J Heart Lung Transplant , vol.18 , Issue.4 , pp. 336-345
    • Taylor, D.O.1    Barr, M.L.2    Radovancevic, B.3
  • 70
    • 0000258596 scopus 로고    scopus 로고
    • European Multicenter Tacrolimus Heart Pilot Study: Three year follow-up
    • Feb;
    • Reichart B, Meiser B, Vigano M, et al. European Multicenter Tacrolimus Heart Pilot Study: three year follow-up. J Heart Lung Transplant 2001 Feb; 20 (2): 249-50
    • (2001) J Heart Lung Transplant , vol.20 , Issue.2 , pp. 249-250
    • Reichart, B.1    Meiser, B.2    Vigano, M.3
  • 71
    • 33645076062 scopus 로고    scopus 로고
    • Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients
    • Apr;
    • Kobashigawa JA, Patel J, Furukawa H, et al. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients. J Heart Lung Transplant 2006 Apr; 25 (4): 434-9
    • (2006) J Heart Lung Transplant , vol.25 , Issue.4 , pp. 434-439
    • Kobashigawa, J.A.1    Patel, J.2    Furukawa, H.3
  • 72
    • 33745833087 scopus 로고    scopus 로고
    • Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients: A large European trial
    • Jun;
    • Grimm M, Rinaldi M, Yonan NA, et al. Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients: a large European trial. Am J Transplant 2006 Jun; 6 (6): 1387-97
    • (2006) Am J Transplant , vol.6 , Issue.6 , pp. 1387-1397
    • Grimm, M.1    Rinaldi, M.2    Yonan, N.A.3
  • 73
    • 33745393847 scopus 로고    scopus 로고
    • Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report
    • Jun;
    • Kobashigawa JA, Miller LW, Russell SD, et al. Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report. Am J Transplant 2006 Jun; 6 (6): 1377-86
    • (2006) Am J Transplant , vol.6 , Issue.6 , pp. 1377-1386
    • Kobashigawa, J.A.1    Miller, L.W.2    Russell, S.D.3
  • 74
    • 0032947542 scopus 로고    scopus 로고
    • Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: Importance of mycophenolic acid therapeutic drug monitoring
    • Feb;
    • Meiser BM, Pfeiffer M, Schmidt D, et al. Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: importance of mycophenolic acid therapeutic drug monitoring. J Heart Lung Transplant 1999 Feb; 18 (2): 143-9
    • (1999) J Heart Lung Transplant , vol.18 , Issue.2 , pp. 143-149
    • Meiser, B.M.1    Pfeiffer, M.2    Schmidt, D.3
  • 75
    • 4143150741 scopus 로고    scopus 로고
    • Tacrolimus or cyclosporine: Which is the better partner for mycophenolate mofetil in heart transplant recipients?
    • Aug 27;
    • Meiser BM, Groetzner J, Kaczmarek I, et al. Tacrolimus or cyclosporine: which is the better partner for mycophenolate mofetil in heart transplant recipients? Transplantation 2004 Aug 27; 78 (4): 591-8
    • (2004) Transplantation , vol.78 , Issue.4 , pp. 591-598
    • Meiser, B.M.1    Groetzner, J.2    Kaczmarek, I.3
  • 76
    • 0030755483 scopus 로고    scopus 로고
    • Tacrolimus: A superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation
    • Aug;
    • Meiser BM, Uberfuhr P, Fuchs A, et al. Tacrolimus: a superior agent to OKT3 for treating cases of persistent rejection after intrathoracic transplantation. J Heart Lung Transplant 1997 Aug; 16 (8): 795-800
    • (1997) J Heart Lung Transplant , vol.16 , Issue.8 , pp. 795-800
    • Meiser, B.M.1    Uberfuhr, P.2    Fuchs, A.3
  • 77
    • 0032988640 scopus 로고    scopus 로고
    • Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients
    • May;
    • Onsager DR, Canver CC, Jahania MS, et al. Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients. J Heart Lung Transplant 1999 May; 18 (5): 448-55
    • (1999) J Heart Lung Transplant , vol.18 , Issue.5 , pp. 448-455
    • Onsager, D.R.1    Canver, C.C.2    Jahania, M.S.3
  • 78
    • 0034041825 scopus 로고    scopus 로고
    • Efficacy of tacrolimus in patients with steroid-resistant cardiac allograft cellular rejection
    • Apr;
    • Yamani MH, Starling RC, Pelegrin D, et al. Efficacy of tacrolimus in patients with steroid-resistant cardiac allograft cellular rejection. J Heart Lung Transplant 2000 Apr; 19 (4): 337-42
    • (2000) J Heart Lung Transplant , vol.19 , Issue.4 , pp. 337-342
    • Yamani, M.H.1    Starling, R.C.2    Pelegrin, D.3
  • 79
    • 20244388105 scopus 로고    scopus 로고
    • A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients: Mycophenolate Mofetil Investigators
    • Aug 27;
    • Kobashigawa J, Miller L, Renlund D, et al. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients: Mycophenolate Mofetil Investigators. Transplantation 1998 Aug 27; 66 (4): 507-15
    • (1998) Transplantation , vol.66 , Issue.4 , pp. 507-515
    • Kobashigawa, J.1    Miller, L.2    Renlund, D.3
  • 80
    • 33749507195 scopus 로고    scopus 로고
    • Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: Analysis of the transplant registry of the International Society for Heart and Lung Transplantation
    • Oct;
    • O'Neill JO, Edwards LB, Taylor DO. Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006 Oct; 25 (10): 1186-91
    • (2006) J Heart Lung Transplant , vol.25 , Issue.10 , pp. 1186-1191
    • O'Neill, J.O.1    Edwards, L.B.2    Taylor, D.O.3
  • 81
    • 0029555832 scopus 로고
    • Hepatotoxicity of transplant immunosuppressive agents
    • Dec;
    • Kowdley KV, Keeffe EB. Hepatotoxicity of transplant immunosuppressive agents. Gastroenterol Clin North Am 1995 Dec; 24 (4): 991-1001
    • (1995) Gastroenterol Clin North Am , vol.24 , Issue.4 , pp. 991-1001
    • Kowdley, K.V.1    Keeffe, E.B.2
  • 82
    • 21044458269 scopus 로고    scopus 로고
    • Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients
    • May;
    • Eisen HJ, Kobashigawa J, Keogh A, et al. Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients. J Heart Lung Transplant 2005 May; 24 (5): 517-25
    • (2005) J Heart Lung Transplant , vol.24 , Issue.5 , pp. 517-525
    • Eisen, H.J.1    Kobashigawa, J.2    Keogh, A.3
  • 83
    • 33745261588 scopus 로고    scopus 로고
    • Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: Reanalysis of the multicenter trial
    • May;
    • Kobashigawa JA, Tobis JM, Mentzer RM, et al. Mycophenolate mofetil reduces intimal thickness by intravascular ultrasound after heart transplant: reanalysis of the multicenter trial. Am J Transplant 2006 May; 6 (5 Pt 1): 993-7
    • (2006) Am J Transplant , vol.6 , Issue.5 PART 1 , pp. 993-997
    • Kobashigawa, J.A.1    Tobis, J.M.2    Mentzer, R.M.3
  • 84
    • 20844432212 scopus 로고    scopus 로고
    • Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients: The IMPROVED multi-centre study
    • Sep;
    • Angermann CE, Stork S, Costard-Jackle A, et al. Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients: the IMPROVED multi-centre study. Eur Heart J 2004 Sep; 25 (18): 1626-34
    • (2004) Eur Heart J , vol.25 , Issue.18 , pp. 1626-1634
    • Angermann, C.E.1    Stork, S.2    Costard-Jackle, A.3
  • 85
    • 10744231167 scopus 로고    scopus 로고
    • Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure
    • Feb 27;
    • Groetzner J, Meiser B, Landwehr P, et al. Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure. Transplantation 2004 Feb 27; 77 (4): 568-74
    • (2004) Transplantation , vol.77 , Issue.4 , pp. 568-574
    • Groetzner, J.1    Meiser, B.2    Landwehr, P.3
  • 86
    • 29144480970 scopus 로고    scopus 로고
    • Sirolimus in cardiac transplantation: Use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity
    • Dec;
    • Kushwaha SS, Khalpey Z, Frantz RP, et al. Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity. J Heart Lung Transplant 2005 Dec; 24 (12): 2129-36
    • (2005) J Heart Lung Transplant , vol.24 , Issue.12 , pp. 2129-2136
    • Kushwaha, S.S.1    Khalpey, Z.2    Frantz, R.P.3
  • 87
    • 0032811642 scopus 로고    scopus 로고
    • Increased incidence of allograft rejection in stable heart transplant recipients after late conversion from mycophenolate mofetil to azathioprine
    • Aug;
    • Taylor DO, Sharma RC, Kfoury AG, et al. Increased incidence of allograft rejection in stable heart transplant recipients after late conversion from mycophenolate mofetil to azathioprine. Clin Transplant 1999 Aug; 13 (4): 296-9
    • (1999) Clin Transplant , vol.13 , Issue.4 , pp. 296-299
    • Taylor, D.O.1    Sharma, R.C.2    Kfoury, A.G.3
  • 88
    • 0034660341 scopus 로고    scopus 로고
    • The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection
    • Jun 15;
    • Yamani MH, Starling RC, Goormastic M, et al. The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection. Transplantation 2000 Jun 15; 69 (11): 2326-30
    • (2000) Transplantation , vol.69 , Issue.11 , pp. 2326-2330
    • Yamani, M.H.1    Starling, R.C.2    Goormastic, M.3
  • 89
    • 33746473566 scopus 로고    scopus 로고
    • Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, Myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: Results of a 12-month, single-blind, randomized, parallel-group, multicenter study
    • Aug;
    • Kobashigawa JA, Renlund DG, Gerosa G, et al. Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, Myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: results of a 12-month, single-blind, randomized, parallel-group, multicenter study. J Heart Lung Transplant 2006 Aug; 25 (8): 935-41
    • (2006) J Heart Lung Transplant , vol.25 , Issue.8 , pp. 935-941
    • Kobashigawa, J.A.1    Renlund, D.G.2    Gerosa, G.3
  • 90
    • 0034082485 scopus 로고    scopus 로고
    • The use of mycophenolate mofetil in transplant recipients
    • May;
    • Mele TS, Halloran PF. The use of mycophenolate mofetil in transplant recipients. Immunopharmacology 2000 May; 47 (2-3): 215-45
    • (2000) Immunopharmacology , vol.47 , Issue.2-3 , pp. 215-245
    • Mele, T.S.1    Halloran, P.F.2
  • 91
    • 23744467925 scopus 로고    scopus 로고
    • Sirolimus: The evidence for clinical pharmacokinetic monitoring
    • Stenton SB, Partovi N, Ensom MH. Sirolimus: the evidence for clinical pharmacokinetic monitoring. Clin Pharmacokinet 2005; 44 (8): 769-86
    • (2005) Clin Pharmacokinet , vol.44 , Issue.8 , pp. 769-786
    • Stenton, S.B.1    Partovi, N.2    Ensom, M.H.3
  • 92
    • 26444567404 scopus 로고    scopus 로고
    • The role of therapeutic monitoring of everolimus in solid organ transplantation
    • Oct;
    • Mabasa VH, Ensom MH. The role of therapeutic monitoring of everolimus in solid organ transplantation. Ther Drug Monit 2005 Oct; 27 (5): 666-76
    • (2005) Ther Drug Monit , vol.27 , Issue.5 , pp. 666-676
    • Mabasa, V.H.1    Ensom, M.H.2
  • 93
    • 20844461132 scopus 로고    scopus 로고
    • Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: A randomized clinical trial
    • Oct 26;
    • Keogh A, Richardson M, Ruygrok P, et al. Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial. Circulation 2004 Oct 26; 110 (17): 2694-700
    • (2004) Circulation , vol.110 , Issue.17 , pp. 2694-2700
    • Keogh, A.1    Richardson, M.2    Ruygrok, P.3
  • 94
    • 33745288559 scopus 로고    scopus 로고
    • Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients
    • May;
    • Kuppahally S, Al-Khaldi A, Weisshaar D, et al. Wound healing complications with de novo sirolimus versus mycophenolate mofetil-based regimen in cardiac transplant recipients. Am J Transplant 2006 May; 6 (5 Pt 1): 986-92
    • (2006) Am J Transplant , vol.6 , Issue.5 PART 1 , pp. 986-992
    • Kuppahally, S.1    Al-Khaldi, A.2    Weisshaar, D.3
  • 95
    • 0038300674 scopus 로고    scopus 로고
    • Use of rapamycin slows progression of cardiac transplantation vasculopathy
    • Jul 8;
    • Mancini D, Pinney S, Burkhoff D, et al. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 2003 Jul 8; 108 (1): 48-53
    • (2003) Circulation , vol.108 , Issue.1 , pp. 48-53
    • Mancini, D.1    Pinney, S.2    Burkhoff, D.3
  • 96
    • 33751579089 scopus 로고    scopus 로고
    • Treatment of allograft vasculopathy in heart transplantation
    • Dec;
    • Segovia J, Gomez-Bueno M, Alonso-Pulpon L. Treatment of allograft vasculopathy in heart transplantation. Expert Opin Pharmacother 2006 Dec; 7 (17): 2369-83
    • (2006) Expert Opin Pharmacother , vol.7 , Issue.17 , pp. 2369-2383
    • Segovia, J.1    Gomez-Bueno, M.2    Alonso-Pulpon, L.3
  • 97
    • 34547592986 scopus 로고    scopus 로고
    • Development of proteinuria after switch to sirolimus based immunosuppression in long-term cardiac transplant patients [abstract]. World Transplant Congress 2006 poster abstracts
    • Aliabadi AZ, Kammerstätter DP, Seebacher G, et al. Development of proteinuria after switch to sirolimus based immunosuppression in long-term cardiac transplant patients [abstract]. World Transplant Congress 2006 poster abstracts. Am J Transplant 2006; 6 Suppl. 2: 562
    • (2006) Am J Transplant , vol.6 , Issue.SUPPL. 2 , pp. 562
    • Aliabadi, A.Z.1    Kammerstätter, D.P.2    Seebacher, G.3
  • 98
    • 20344377982 scopus 로고    scopus 로고
    • Kaposi sarcoma in solid organ transplant recipients: A single center report
    • May;
    • Boeckle E, Boesmueller C, Wiesmayr S, et al. Kaposi sarcoma in solid organ transplant recipients: a single center report. Transplant Proc 2005 May; 37 (4): 1905-9
    • (2005) Transplant Proc , vol.37 , Issue.4 , pp. 1905-1909
    • Boeckle, E.1    Boesmueller, C.2    Wiesmayr, S.3
  • 100
    • 19244366021 scopus 로고    scopus 로고
    • Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients
    • Aug 28;
    • Eisen HJ, Tuzcu EM, Dorent R, et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 2003 Aug 28; 349 (9): 847-58
    • (2003) N Engl J Med , vol.349 , Issue.9 , pp. 847-858
    • Eisen, H.J.1    Tuzcu, E.M.2    Dorent, R.3
  • 101
    • 0141433268 scopus 로고    scopus 로고
    • Everolimus in de novo cardiac transplantation: Pharmacokinetics, therapeutic range, and influence on cyclosporine exposure
    • Oct;
    • Kovarik JM, Eisen H, Dorent R, et al. Everolimus in de novo cardiac transplantation: pharmacokinetics, therapeutic range, and influence on cyclosporine exposure. J Heart Lung Transplant 2003 Oct; 22 (10): 1117-25
    • (2003) J Heart Lung Transplant , vol.22 , Issue.10 , pp. 1117-1125
    • Kovarik, J.M.1    Eisen, H.2    Dorent, R.3
  • 102
    • 15044365786 scopus 로고    scopus 로고
    • Hummel M. Recommendations for use of Certican (everolimus) after heart transplantation: results from a German and Austrian Consensus Conference. J Heart Lung Transplant 2005 Apr; 24 (4 Suppl.): S196-200
    • Hummel M. Recommendations for use of Certican (everolimus) after heart transplantation: results from a German and Austrian Consensus Conference. J Heart Lung Transplant 2005 Apr; 24 (4 Suppl.): S196-200
  • 104
    • 16244380792 scopus 로고    scopus 로고
    • Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients
    • Apr;
    • Opelz G, Dohler B, Laux G, et al. Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients. Am J Transplant 2005 Apr; 5 (4 Pt 1): 720-8
    • (2005) Am J Transplant , vol.5 , Issue.4 PART 1 , pp. 720-728
    • Opelz, G.1    Dohler, B.2    Laux, G.3
  • 105
    • 33746210045 scopus 로고    scopus 로고
    • Effects of early steroid withdrawal after heart transplantation
    • Aug;
    • Rosenbaum DH, Adams BC, Mitchell JD, et al. Effects of early steroid withdrawal after heart transplantation. Ann Thorac Surg 2006 Aug; 82 (2): 637-44
    • (2006) Ann Thorac Surg , vol.82 , Issue.2 , pp. 637-644
    • Rosenbaum, D.H.1    Adams, B.C.2    Mitchell, J.D.3
  • 106
    • 33748138829 scopus 로고    scopus 로고
    • Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients
    • Sep;
    • Kobashigawa JA, Starling RC, Mehra MR, et al. Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients. J Heart Lung Transplant 2006 Sep; 25 (9): 1063-9
    • (2006) J Heart Lung Transplant , vol.25 , Issue.9 , pp. 1063-1069
    • Kobashigawa, J.A.1    Starling, R.C.2    Mehra, M.R.3
  • 107
    • 0024400666 scopus 로고
    • Cyclosporine and azathioprine immunosuppression without maintenance steroids: A prospective randomized trial
    • May-Jun;
    • Esmore DS, Spratt PM, Keogh AM, et al. Cyclosporine and azathioprine immunosuppression without maintenance steroids: a prospective randomized trial. J Heart Transplant 1989 May-Jun; 8 (3): 194-9
    • (1989) J Heart Transplant , vol.8 , Issue.3 , pp. 194-199
    • Esmore, D.S.1    Spratt, P.M.2    Keogh, A.M.3
  • 108
    • 0025764723 scopus 로고
    • Cardiac transplantation with corticosteroid-free immunosuppression: Long-term results
    • Aug;
    • Lee KF, Pierce JD, Hess ML, et al. Cardiac transplantation with corticosteroid-free immunosuppression: long-term results. Ann Thorac Surg 1991 Aug; 52 (2): 211-7
    • (1991) Ann Thorac Surg , vol.52 , Issue.2 , pp. 211-217
    • Lee, K.F.1    Pierce, J.D.2    Hess, M.L.3
  • 109
    • 0023188910 scopus 로고
    • Feasibility of discontinuation of corticosteroid maintenance therapy in heart transplantation
    • Mar-Apr;
    • Renlund DG, O'Connell JB, Gilbert EM, et al. Feasibility of discontinuation of corticosteroid maintenance therapy in heart transplantation. J Heart Transplant 1987 Mar-Apr; 6 (2): 71-8
    • (1987) J Heart Transplant , vol.6 , Issue.2 , pp. 71-78
    • Renlund, D.G.1    O'Connell, J.B.2    Gilbert, E.M.3
  • 110
    • 0026720376 scopus 로고
    • Five-year follow-up of a randomized double-drug versus triple-drug therapy immunosuppressive trial after heart transplantation
    • May-Jun;
    • Keogh A, Macdonald P, Mundy J, et al. Five-year follow-up of a randomized double-drug versus triple-drug therapy immunosuppressive trial after heart transplantation. J Heart Lung Transplant 1992 May-Jun; 11 (3 Pt 1): 550-5
    • (1992) J Heart Lung Transplant , vol.11 , Issue.3 PART 1 , pp. 550-555
    • Keogh, A.1    Macdonald, P.2    Mundy, J.3
  • 111
    • 0036242931 scopus 로고    scopus 로고
    • Survival and incidence of acute rejection in heart transplant recipients undergoing successful withdrawal from steroid therapy
    • May;
    • Felkel TO, Smith AL, Reichenspurner HC, et al. Survival and incidence of acute rejection in heart transplant recipients undergoing successful withdrawal from steroid therapy. J Heart Lung Transplant 2002 May; 21 (5): 530-9
    • (2002) J Heart Lung Transplant , vol.21 , Issue.5 , pp. 530-539
    • Felkel, T.O.1    Smith, A.L.2    Reichenspurner, H.C.3
  • 112
    • 33745183288 scopus 로고    scopus 로고
    • Improved survival with statins, angiotensin receptor blockers, and steroid weaning after heart transplantation
    • Jun;
    • Lubitz SA, Baran DA, Alwarshetty MM, et al. Improved survival with statins, angiotensin receptor blockers, and steroid weaning after heart transplantation. Transplant Proc 2006 Jun; 38 (5): 1501-6
    • (2006) Transplant Proc , vol.38 , Issue.5 , pp. 1501-1506
    • Lubitz, S.A.1    Baran, D.A.2    Alwarshetty, M.M.3
  • 113
    • 0033118312 scopus 로고    scopus 로고
    • Immunosenescence: Impact in the young as well as the old?
    • Apr 1;
    • Pawelec G. Immunosenescence: impact in the young as well as the old? Mech Ageing Dev 1999 Apr 1; 108 (1): 1-7
    • (1999) Mech Ageing Dev , vol.108 , Issue.1 , pp. 1-7
    • Pawelec, G.1
  • 114
    • 0034458563 scopus 로고    scopus 로고
    • Clinical relevance of age-related immune dysfunction
    • Aug;
    • Castle SC. Clinical relevance of age-related immune dysfunction. Clin Infect Dis 2000 Aug; 31 (2): 578-85
    • (2000) Clin Infect Dis , vol.31 , Issue.2 , pp. 578-585
    • Castle, S.C.1
  • 115
    • 0036345218 scopus 로고    scopus 로고
    • Rejection and recipient age
    • Aug;
    • Bradley BA. Rejection and recipient age. Transpl Immunol 2002 Aug; 10 (2-3): 125-32
    • (2002) Transpl Immunol , vol.10 , Issue.2-3 , pp. 125-132
    • Bradley, B.A.1
  • 116
    • 1942469969 scopus 로고    scopus 로고
    • Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients
    • Apr;
    • Paya C, Humar A, Dominguez E, et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004 Apr; 4 (4): 611-20
    • (2004) Am J Transplant , vol.4 , Issue.4 , pp. 611-620
    • Paya, C.1    Humar, A.2    Dominguez, E.3
  • 117
    • 0035865243 scopus 로고    scopus 로고
    • Comparison between antigenemia and a quantitative-competitive polymerase chain reaction for the diagnosis of cytomegalovirus infection after heart transplantation
    • Feb 15;
    • Camargo LF, Uip DE, Simpson AA, et al. Comparison between antigenemia and a quantitative-competitive polymerase chain reaction for the diagnosis of cytomegalovirus infection after heart transplantation. Transplantation 2001 Feb 15; 71 (3): 412-7
    • (2001) Transplantation , vol.71 , Issue.3 , pp. 412-417
    • Camargo, L.F.1    Uip, D.E.2    Simpson, A.A.3
  • 118
    • 33749526844 scopus 로고    scopus 로고
    • Prevalence of metabolic syndrome in heart transplant patients: Role of previous cardiopathy and years since the procedure: the TRACA study
    • Oct;
    • Cordero Fort A, Gavira JJ, Alegría-Barrero E, et al. Prevalence of metabolic syndrome in heart transplant patients: role of previous cardiopathy and years since the procedure: the TRACA study. J Heart Lung Transplant 2006 Oct; 25 (10): 1192-8
    • (2006) J Heart Lung Transplant , vol.25 , Issue.10 , pp. 1192-1198
    • Cordero Fort, A.1    Gavira, J.J.2    Alegría-Barrero, E.3
  • 119
    • 0028954578 scopus 로고
    • Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation
    • Jan-Feb;
    • Olivari MT, Jessen ME, Baldwin BJ, et al. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation. J Heart Lung Transplant 1995 Jan-Feb; 14 (1 Pt 1): 127-35
    • (1995) J Heart Lung Transplant , vol.14 , Issue.1 PART 1 , pp. 127-135
    • Olivari, M.T.1    Jessen, M.E.2    Baldwin, B.J.3
  • 120
    • 20744457904 scopus 로고    scopus 로고
    • Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: The Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion
    • Jul;
    • White M, Haddad H, Leblanc MH, et al. Conversion from cyclosporine microemulsion to tacrolimus-based immunoprophylaxis improves cholesterol profile in heart transplant recipients with treated but persistent dyslipidemia: the Canadian multicentre randomized trial of tacrolimus vs cyclosporine microemulsion. J Heart Lung Transplant 2005 Jul; 24 (7): 798-809
    • (2005) J Heart Lung Transplant , vol.24 , Issue.7 , pp. 798-809
    • White, M.1    Haddad, H.2    Leblanc, M.H.3
  • 121
    • 1142286392 scopus 로고    scopus 로고
    • Bone loss after cardiac transplantation
    • Feb 19;
    • Lindsay R. Bone loss after cardiac transplantation. N Engl J Med 2004 Feb 19; 350 (8): 751-4
    • (2004) N Engl J Med , vol.350 , Issue.8 , pp. 751-754
    • Lindsay, R.1
  • 122
    • 0345435114 scopus 로고    scopus 로고
    • Progression of steroid-associated osteoporosis after heart transplantation
    • Jan;
    • Cremer J, Struber M, Wagenbreth I, et al. Progression of steroid-associated osteoporosis after heart transplantation. Ann Thorac Surg 1999 Jan; 67 (1): 130-3
    • (1999) Ann Thorac Surg , vol.67 , Issue.1 , pp. 130-133
    • Cremer, J.1    Struber, M.2    Wagenbreth, I.3
  • 123
    • 0037372164 scopus 로고    scopus 로고
    • Effects of cyclosporine on osteoclast activity: Inhibition of calcineurin activity with minimal effects on bone resorption and acid transport activity
    • Mar;
    • Williams JP, McKenna MA, Thames AM, et al. Effects of cyclosporine on osteoclast activity: inhibition of calcineurin activity with minimal effects on bone resorption and acid transport activity. J Bone Miner Res 2003 Mar; 18 (3): 451-7
    • (2003) J Bone Miner Res , vol.18 , Issue.3 , pp. 451-457
    • Williams, J.P.1    McKenna, M.A.2    Thames, A.M.3
  • 124
    • 0033819810 scopus 로고    scopus 로고
    • Bone loss after renal transplantation: Role of hyperparathyroidism, acidosis, cyclosporine and systemic disease
    • Oct;
    • Heaf J, Tvedegaard E, Kanstrup IL, et al. Bone loss after renal transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease. Clin Transplant 2000 Oct; 14 (5): 457-63
    • (2000) Clin Transplant , vol.14 , Issue.5 , pp. 457-463
    • Heaf, J.1    Tvedegaard, E.2    Kanstrup, I.L.3
  • 125
    • 0030852304 scopus 로고    scopus 로고
    • Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure
    • Sep;
    • Shane E, Mancini D, Aaronson K, et al. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 1997 Sep; 103 (3): 197-207
    • (1997) Am J Med , vol.103 , Issue.3 , pp. 197-207
    • Shane, E.1    Mancini, D.2    Aaronson, K.3
  • 126
    • 0037390157 scopus 로고    scopus 로고
    • Congestive heart failure is associated with the rate of bone loss
    • Apr;
    • Nishio K, Mukae S, Aoki S, et al. Congestive heart failure is associated with the rate of bone loss. J Intern Med 2003 Apr; 253 (4): 439-46
    • (2003) J Intern Med , vol.253 , Issue.4 , pp. 439-446
    • Nishio, K.1    Mukae, S.2    Aoki, S.3
  • 127
    • 0042666846 scopus 로고    scopus 로고
    • Pathogenesis of bone loss in heart transplant candidates and recipients
    • Aug;
    • Kerschan-Schindl K, Strametz-Juranek J, Heinze G, et al. Pathogenesis of bone loss in heart transplant candidates and recipients. J Heart Lung Transplant 2003 Aug; 22 (8): 843-50
    • (2003) J Heart Lung Transplant , vol.22 , Issue.8 , pp. 843-850
    • Kerschan-Schindl, K.1    Strametz-Juranek, J.2    Heinze, G.3
  • 128
    • 33644674991 scopus 로고    scopus 로고
    • Markers of bone metabolism in congestive heart failure
    • Apr;
    • Zittermann A, Schleithoff SS, Koerfer R. Markers of bone metabolism in congestive heart failure. Clin Chim Acta 2006 Apr; 366 (1-2): 27-36
    • (2006) Clin Chim Acta , vol.366 , Issue.1-2 , pp. 27-36
    • Zittermann, A.1    Schleithoff, S.S.2    Koerfer, R.3
  • 129
    • 33646766103 scopus 로고    scopus 로고
    • Comparison of calcitonin versus calcitonin + resistance exercise as prophylaxis for osteoporosis in heart transplant recipients
    • Apr 27;
    • Braith RW, Magyari PM, Fulton MN, et al. Comparison of calcitonin versus calcitonin + resistance exercise as prophylaxis for osteoporosis in heart transplant recipients. Transplantation 2006 Apr 27; 81 (8): 1191-5
    • (2006) Transplantation , vol.81 , Issue.8 , pp. 1191-1195
    • Braith, R.W.1    Magyari, P.M.2    Fulton, M.N.3
  • 130
    • 22744458717 scopus 로고    scopus 로고
    • Bisphosphonates routine in prevention of post-transplant osteoporosis? [letter]
    • Aug;
    • Hofle G, Holzmuller H, Drexel H. Bisphosphonates routine in prevention of post-transplant osteoporosis? [letter]. J Bone Miner Res 2005 Aug; 20 (8): 1482
    • (2005) J Bone Miner Res , vol.20 , Issue.8 , pp. 1482
    • Hofle, G.1    Holzmuller, H.2    Drexel, H.3
  • 131
    • 19044362279 scopus 로고    scopus 로고
    • Heart transplant recipient clinical profile improvement following mycophenolate mofetil late incorporation into the treatment schedule
    • Jun;
    • Manito N, Kaplinsky EJ, Roca J, et al. Heart transplant recipient clinical profile improvement following mycophenolate mofetil late incorporation into the treatment schedule. Clin Transplant 2005 Jun; 19 (3): 304-8
    • (2005) Clin Transplant , vol.19 , Issue.3 , pp. 304-308
    • Manito, N.1    Kaplinsky, E.J.2    Roca, J.3
  • 132
    • 0036435748 scopus 로고    scopus 로고
    • The impact of diabetes mellitus at the time of heart transplantation on long-term survival
    • Nov;
    • Czerny M, Sahin V, Fasching P, et al. The impact of diabetes mellitus at the time of heart transplantation on long-term survival. Diabetologia 2002 Nov; 45 (11): 1498-508
    • (2002) Diabetologia , vol.45 , Issue.11 , pp. 1498-1508
    • Czerny, M.1    Sahin, V.2    Fasching, P.3
  • 133
    • 2342427572 scopus 로고    scopus 로고
    • Heart transplantation in diabetic recipients: A decade review of 161 patients at Columbia Presbyterian
    • May;
    • Morgan JA, John R, Weinberg AD, et al. Heart transplantation in diabetic recipients: a decade review of 161 patients at Columbia Presbyterian. J Thorac Cardiovasc Surg 2004 May; 127 (5): 1486-92
    • (2004) J Thorac Cardiovasc Surg , vol.127 , Issue.5 , pp. 1486-1492
    • Morgan, J.A.1    John, R.2    Weinberg, A.D.3
  • 134
    • 33751249907 scopus 로고    scopus 로고
    • Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: An analysis of the United Network of Organ Sharing database
    • Nov 21;
    • Russo MJ, Chen JM, Hong KN, et al. Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing database. Circulation 2006 Nov 21; 114 (21): 2280-7
    • (2006) Circulation , vol.114 , Issue.21 , pp. 2280-2287
    • Russo, M.J.1    Chen, J.M.2    Hong, K.N.3
  • 135
    • 0033983666 scopus 로고    scopus 로고
    • Predicting the occurrence of diabetes mellitus in recipients of heart transplants
    • Jan;
    • Depczynski B, Daly B, Campbell LV, et al. Predicting the occurrence of diabetes mellitus in recipients of heart transplants. Diabet Med 2000 Jan; 17 (1): 15-9
    • (2000) Diabet Med , vol.17 , Issue.1 , pp. 15-19
    • Depczynski, B.1    Daly, B.2    Campbell, L.V.3
  • 136
    • 21244500992 scopus 로고    scopus 로고
    • Corticosteroid weaning in the tacrolimus and mycophenolate era in heart transplantation: Clinical and neurohormonal benefits
    • Dec;
    • Mehra MR, Uber PA, Park MH, et al. Corticosteroid weaning in the tacrolimus and mycophenolate era in heart transplantation: clinical and neurohormonal benefits. Transplant Proc 2004 Dec; 36 (10): 3152-5
    • (2004) Transplant Proc , vol.36 , Issue.10 , pp. 3152-3155
    • Mehra, M.R.1    Uber, P.A.2    Park, M.H.3
  • 137
    • 0035993711 scopus 로고    scopus 로고
    • Tacrolimus and new onset diabetes mellitus: The effect of steroid weaning
    • Aug;
    • Baran DA, Ashkar J, Galin ID, et al. Tacrolimus and new onset diabetes mellitus: the effect of steroid weaning. Transplant Proc 2002 Aug; 34 (5): 1711-2
    • (2002) Transplant Proc , vol.34 , Issue.5 , pp. 1711-1712
    • Baran, D.A.1    Ashkar, J.2    Galin, I.D.3
  • 138
    • 0042360213 scopus 로고    scopus 로고
    • Chronic renal failure after transplantation of a nonrenal organ
    • Sep 4;
    • Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003 Sep 4; 349 (10): 931-40
    • (2003) N Engl J Med , vol.349 , Issue.10 , pp. 931-940
    • Ojo, A.O.1    Held, P.J.2    Port, F.K.3
  • 139
    • 0029987555 scopus 로고    scopus 로고
    • Insights into chronic cyclosporine nephrotoxicity
    • Bennett WM. Insights into chronic cyclosporine nephrotoxicity. Int J Clin Pharmacol Ther 1996; 34: 515-9
    • (1996) Int J Clin Pharmacol Ther , vol.34 , pp. 515-519
    • Bennett, W.M.1
  • 140
    • 0029806297 scopus 로고    scopus 로고
    • Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy
    • Bennett WM, DeMattos A, Meyer MM, et al. Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy. Kidney Int 1996; 50: 1089-100
    • (1996) Kidney Int , vol.50 , pp. 1089-1100
    • Bennett, W.M.1    DeMattos, A.2    Meyer, M.M.3
  • 141
    • 0025078137 scopus 로고
    • The spectrum of ciclosporin nephrotoxicity
    • Puschett JB, Greenberg A, Holley J, et al. The spectrum of ciclosporin nephrotoxicity. Am J Nephrol 1990; 10: 296-309
    • (1990) Am J Nephrol , vol.10 , pp. 296-309
    • Puschett, J.B.1    Greenberg, A.2    Holley, J.3
  • 142
    • 0028861626 scopus 로고
    • Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: Preliminary results from US Multicenter trial
    • Porayko MK, Gonwa TA, Klintmalm GB, et al. Comparing nephrotoxicity of FK 506 and cyclosporine regimens after liver transplantation: preliminary results from US Multicenter trial. Transplant Proc 1995; 27: 1114-6
    • (1995) Transplant Proc , vol.27 , pp. 1114-1116
    • Porayko, M.K.1    Gonwa, T.A.2    Klintmalm, G.B.3
  • 143
    • 0028046793 scopus 로고
    • A prospective study of renal structure and function in psoriasis patients treated with cyclosporin
    • Young EW, Ellis CN, Messana JM, et al. A prospective study of renal structure and function in psoriasis patients treated with cyclosporin. Kidney Int 1994; 46: 1216-22
    • (1994) Kidney Int , vol.46 , pp. 1216-1222
    • Young, E.W.1    Ellis, C.N.2    Messana, J.M.3
  • 144
    • 0026808461 scopus 로고
    • The pathologic changes in long-term heart and lung transplant survivors
    • Jul-Aug;
    • Billingham ME. The pathologic changes in long-term heart and lung transplant survivors. J Heart Lung Transplant 1992 Jul-Aug; 11 (4 Pt 2): S252-7
    • (1992) J Heart Lung Transplant , vol.11 , Issue.4 PART 2
    • Billingham, M.E.1
  • 145
    • 0034466751 scopus 로고    scopus 로고
    • What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?
    • Kobashigawa JA. What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy? Curr Control Trials Cardiovasc Med 2000; 1: 166-71
    • (2000) Curr Control Trials Cardiovasc Med , vol.1 , pp. 166-171
    • Kobashigawa, J.A.1
  • 146
    • 20944441873 scopus 로고    scopus 로고
    • Multicenter intravascular ultrasound validation study among heart transplant recipients: Outcomes after five years
    • Kobashigawa JA, Tobis JM, Starling RC, et al. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. J Am Coll Cardiol 2005; 45 (9): 1532-7
    • (2005) J Am Coll Cardiol , vol.45 , Issue.9 , pp. 1532-1537
    • Kobashigawa, J.A.1    Tobis, J.M.2    Starling, R.C.3
  • 147
    • 16244406560 scopus 로고    scopus 로고
    • Improving outcomes in heart transplantation: The potential of proliferation signal inhibitors
    • Eisen H, Kobashigawa J, Starling RC, et al. Improving outcomes in heart transplantation: the potential of proliferation signal inhibitors. Transplant Proc 2005; 37 (4 Suppl.): 4-17S
    • (2005) Transplant Proc , vol.37 , Issue.4 SUPPL.
    • Eisen, H.1    Kobashigawa, J.2    Starling, R.C.3
  • 148
    • 33646095991 scopus 로고    scopus 로고
    • Influence of polyclonal anti-thymocyte globulins upon ischemia-reperfusion injury in a non-human primate model
    • Apr;
    • Beiras-Fernandez A, Chappell D, Hammer C, et al. Influence of polyclonal anti-thymocyte globulins upon ischemia-reperfusion injury in a non-human primate model. Transpl Immunol 2006 Apr; 15 (4): 273-9
    • (2006) Transpl Immunol , vol.15 , Issue.4 , pp. 273-279
    • Beiras-Fernandez, A.1    Chappell, D.2    Hammer, C.3
  • 149
    • 33644616283 scopus 로고    scopus 로고
    • In vivo visualization of the effect of polyclonal antithymocyte globulins on the microcirculation after ischemia/reperfusion in a primate model
    • Feb 27;
    • Chappell D, Beiras-Fernandez A, Hammer C, et al. In vivo visualization of the effect of polyclonal antithymocyte globulins on the microcirculation after ischemia/reperfusion in a primate model. Transplantation 2006 Feb 27; 81 (4): 552-8
    • (2006) Transplantation , vol.81 , Issue.4 , pp. 552-558
    • Chappell, D.1    Beiras-Fernandez, A.2    Hammer, C.3
  • 150
    • 33750343813 scopus 로고    scopus 로고
    • Case report: Long-term outcome of a heart transplant recipient switched to everolimus after an acute myocardial infarction
    • Oct 27;
    • Frigerio M, Cipriani MG, Roubina E, et al. Case report: long-term outcome of a heart transplant recipient switched to everolimus after an acute myocardial infarction. Transplantation 2006 Oct 27; 82 (8 Suppl.): S19-23
    • (2006) Transplantation , vol.82 , Issue.8 SUPPL.
    • Frigerio, M.1    Cipriani, M.G.2    Roubina, E.3
  • 151
    • 1942476133 scopus 로고    scopus 로고
    • Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients
    • Ulrich C, Schmook T, Sachse MM, et al. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg 2004; 30 (4 Pt 2): 622-7
    • (2004) Dermatol Surg , vol.30 , Issue.4 PART 2 , pp. 622-627
    • Ulrich, C.1    Schmook, T.2    Sachse, M.M.3
  • 152
    • 2942587074 scopus 로고    scopus 로고
    • Cancer after kidney transplantation in the United States
    • Kasiske BL, Snyder JJ, Gilbertson DT, et al. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4 (6): 905-13
    • (2004) Am J Transplant , vol.4 , Issue.6 , pp. 905-913
    • Kasiske, B.L.1    Snyder, J.J.2    Gilbertson, D.T.3
  • 153
    • 33645458234 scopus 로고    scopus 로고
    • Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation
    • Campistol JM, Eris J, Oberbauer R, et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol 2006; 17 (2): 581-9
    • (2006) J Am Soc Nephrol , vol.17 , Issue.2 , pp. 581-589
    • Campistol, J.M.1    Eris, J.2    Oberbauer, R.3
  • 154
    • 27644436740 scopus 로고    scopus 로고
    • Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies
    • Kauffman HM, Cherikh WS, Cheng Y, et al. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation 2005; 80 (7): 883-9
    • (2005) Transplantation , vol.80 , Issue.7 , pp. 883-889
    • Kauffman, H.M.1    Cherikh, W.S.2    Cheng, Y.3
  • 155
    • 33745787242 scopus 로고    scopus 로고
    • Potential role of proliferation signal inhibitors on atherosclerosis in renal transplant patients
    • Andres V, Castro C, Campistol JM. Potential role of proliferation signal inhibitors on atherosclerosis in renal transplant patients. Nephrol Dial Transplant 2006; 21 Suppl. 3: iii14-7
    • (2006) Nephrol Dial Transplant , vol.21 , Issue.SUPPL. 3
    • Andres, V.1    Castro, C.2    Campistol, J.M.3
  • 156
    • 29544442185 scopus 로고    scopus 로고
    • Everolimus (Certican®) in heart transplantation: Optimizing renal function through minimizing cyclosporine exposure
    • Dec;
    • Lehmkuhl H, Ross H, Eisen H, et al. Everolimus (Certican®) in heart transplantation: optimizing renal function through minimizing cyclosporine exposure. Transplant Proc 2005 Dec; 37 (10): 4145-9
    • (2005) Transplant Proc , vol.37 , Issue.10 , pp. 4145-4149
    • Lehmkuhl, H.1    Ross, H.2    Eisen, H.3
  • 157
    • 24044443235 scopus 로고    scopus 로고
    • Pharmacokinetic considerations relating to tacrolimus dosing in the elderly
    • Staatz CE, Tett SE. Pharmacokinetic considerations relating to tacrolimus dosing in the elderly. Drugs Aging 2005; 22 (5): 541-57
    • (2005) Drugs Aging , vol.22 , Issue.5 , pp. 541-557
    • Staatz, C.E.1    Tett, S.E.2
  • 158
    • 1942458255 scopus 로고    scopus 로고
    • Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences to tissue dosimetry
    • Clevell H, Gentry P, Covington TR, et al. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences to tissue dosimetry. Toxicol Sci 2004; 79: 381-93
    • (2004) Toxicol Sci , vol.79 , pp. 381-393
    • Clevell, H.1    Gentry, P.2    Covington, T.R.3
  • 159
    • 0012642273 scopus 로고    scopus 로고
    • Pharmacokinetics
    • Crome P, Ford G, editors, London: Imperial College Press
    • O'Mahoney S. Pharmacokinetics. In: Crome P, Ford G, editors. Drugs and the older population. London: Imperial College Press, 2000: 58-89
    • (2000) Drugs and the older population , pp. 58-89
    • O'Mahoney, S.1
  • 160
    • 33748057835 scopus 로고    scopus 로고
    • An up-date review on individualized dosage adjustments of calcineurin inhibitors in organ transplant patients
    • Masuda S, Inui KI. An up-date review on individualized dosage adjustments of calcineurin inhibitors in organ transplant patients. Pharmacol Ther 2006; 112: 184-98
    • (2006) Pharmacol Ther , vol.112 , pp. 184-198
    • Masuda, S.1    Inui, K.I.2
  • 161
    • 0242334031 scopus 로고    scopus 로고
    • Drug therapy in the elderly
    • Noble RE. Drug therapy in the elderly. Metabolism 2003; 52 (10 Suppl. 2): 27-30
    • (2003) Metabolism , vol.52 , Issue.10 SUPPL. 2 , pp. 27-30
    • Noble, R.E.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.